PARP6 and hepatoblastoma: PARP6 expression is a biomarker for good prognosis of colorectal cancers (CRC) (Tuncel et al., 2012) and the increased methylation of PARP6 is positively correlated with poor prognosis of hepatoblastoma (Honda et al., 2016), indicating the tumor suppressor role of PARP6.